States Too Late To Question Report In MDL, Drugmakers Say

Law360 (April 7, 2021, 11:38 PM EDT) -- A coalition of generic-drug companies filed an opposition brief on Wednesday blasting a group of state attorneys general for contesting a special master's recommendation in sprawling multidistrict litigation accusing much of the generic-drug industry of price-fixing, arguing that the states' motion is untimely.

The pharmaceutical companies argued in their nine-page brief that, in addition to filing the objection too late, the state attorneys general bid might also "seek to re-litigate settled issues."

On Monday, the state plaintiffs asked the court for leave so that they could submit a brief in response to a special master's supplemental report and recommendation filed in...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!